Scarica l'app Stockscreener
30.43
0.91%
-0.28
Dopo l'orario di chiusura:
30.87
0.44
+1.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$30.71
Aprire:
$30.32
Volume 24 ore:
3.91M
Relative Volume:
0.81
Capitalizzazione di mercato:
$15.66B
Reddito:
$17.28B
Utile/perdita netta:
$108.00M
Rapporto P/E:
152.15
EPS:
0.2
Flusso di cassa netto:
$391.00M
1 W Prestazione:
-0.33%
1M Prestazione:
+5.70%
6M Prestazione:
-15.71%
1 anno Prestazione:
-17.51%
Intervallo 1D:
$30.18
$31.08
Intervallo di 1 settimana:
$30.18
$32.60
Portata 52W:
$26.25
$40.49
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(847) 948-2000
Indirizzo
ONE BAXTER PKWY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
30.43 | 15.66B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
531.82 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
167.00 | 58.65B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
97.38 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.66 | 35.34B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.57 | 16.25B | 3.90B | 392.30M | 288.10M | 1.95 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Call Transcript - Insider Monkey
Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica
Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Baxter Intl (BAX): Wells Fargo Lowers Price Target to $33 | BAX Stock News - GuruFocus
Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus
Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com
Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com
JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ... - Yahoo
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS Surpass Expectations - GuruFocus
Baxter International Reports Strong Q1 2025 Results - TipRanks
State of Tennessee Department of Treasury Sells 69,945 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Surpasses Q1 2025 Expectations - TipRanks
Baxter International, Deerfield-based maker of IV fluid and pharmaceuticals, expects tariff impact of $60 to $70M - Chicago Tribune
Balanced Outlook on Baxter International: Strong Performance with Margin Concerns - TipRanks
Baxter International Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:BAX) - Seeking Alpha
Baxter Earnings: Elevated Medical Utilization Mildly Boosts 2025 Outlook Despite Tariff Concerns - Morningstar
Evercore ISI Adjusts Baxter International Price Target to $44 From $45, Maintains Outperform Rating - marketscreener.com
Baxter International (BAX) Stock Climbs on Strong Earnings and R - GuruFocus
Baxter stock rises on earnings beat, guidance raise - MSN
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y - TradingView
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps - Benzinga
Baxter stock rises on earnings beat, guidance raise (BAX:NYSE) - Seeking Alpha
Baxter International Surpasses Revenue Expectations in Q1 2025News and Statistics - IndexBox
Earnings call transcript: Baxter International beats Q1 2025 expectations - Investing.com
Earnings call transcript: Baxter International beats Q1 2025 expectations By Investing.com - Investing.com India
Baxter’s (NYSE:BAX) Q1: Beats On Revenue - Yahoo Finance
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Baxter posts strong U.S. sales, anticipates $60M hit from tariffs - Crain's Chicago Business
Baxter (BAX) Surpasses Q1 Revenue Forecast Amid Strategic Transf - GuruFocus
Baxter (BAX) Updates Sales and Earnings Outlook | BAX Stock News - GuruFocus
Baxter tops quarterly estimates on strong demand for medical devices - TradingView
Baxter International's Q1 Adjusted Net Income Drops, Revenue Rises; Full-Year 2025 Guidance Revised - marketscreener.com
Baxter Q1 2025 slides: Sales beat expectations, EPS surges 53%, guidance raised - Investing.com Australia
Baxter International Inc Surpasses Q1 2025 Estimates with $0.55 EPS and $2.63 Billion Revenue - GuruFocus
Baxter Reports First-Quarter 2025 Results - Baxter
Baxter Reports First-Quarter 2025 Results | BAX Stock News - GuruFocus
Baxter International Boosts FY25 OutlookUpdate - Nasdaq
Baxter International Inc. Q1 Profit Increases, Beats Estimates - Nasdaq
Baxter shares rise as Q1 earnings top estimates, guidance raised - Investing.com Australia
Baxter shares rise as Q1 earnings top estimates, guidance raised By Investing.com - Investing.com India
Baxter International Inc. Reports First-Quarter 2025 Results - TradingView
Earnings Flash (BAX) Baxter Intl. Reports Q1 Adjusted EPS $0.62, vs. FactSet Est of $0.48 - marketscreener.com
BlackRock, Inc. Reduces Stake in Baxter International Inc. - GuruFocus
Bullish Trends in Baxter (BAX) as Call Options Surge | BAX Stock News - GuruFocus
BI Asset Management Fondsmaeglerselskab A S Acquires Shares of 14,156 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter call volume above normal and directionally bullish - TipRanks
Baxter International Earnings Preview: Market Anticipates Resilient PerformanceNews and Statistics - IndexBox
Baxter (BAX) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):